Влияние соматотропного гормона и интерлейкина-1 на функции фагоцитирующих клеток и его анализ у детей в зависимости от возраста
Диссертация
Типичными представителями разных уровней регуляции иммунной системы — системного и местного — являются соматотропный гормон (СТГ) и интерлейкин — 1 (1Ь-1). Анализируя их химическое строение, клеткимишени, механизмы взаимодействия с рецепторами, иммуномодулирующее действие, следует отметить существование общих свойств. Как соматотропный гормон, так и 1Ь-1 стимулируют увеличение размеров… Читать ещё >
Список литературы
- Балаболкин М.И. СТГ передней доли гипофиза. М.: Наука. — 1981. — 149С.
- Балаболкин М.И. Эндокринология. М.: Универсум паблишинг, 1998. -500C.
- Бахметьев Б.А. Влияние тироксина на формирование первичного иммунного ответа// Совершенствование методов исследования иммунитета и иммунодиагностики. Сб. научн. Тр. Пермский гос. мед. инст. — 1982. -Т.156. — С.54−56.
- Гордиенко С.М. Сравнительная оценка результатов восстановления нитросинего тетразолия при микроскопическом и спектрофотометрическом вариантах метода с различными солями тетразолия.// Лабораторное дело. 1983. — № 2. — С. 21 — 24.
- Здоровский П.Ф. О физиологических аспектах иммуногенеза и его регуляции// В .АМН СССР. 1978. — Т.17,№ 4. — С. 57−65.
- Каплин В.Н., Кузнецов В. Ф., Орнебесова Т. П., Методические аспекты изучения фагоцитоза // I съезд иммунологов России: Тезисы докладов, Новосибирск, 1992. С. 200 — 201.
- Кеворков H.H., Шилов Ю. И., Ширшев C.B., Черешнев В. А. Гормоны репродукции в регуляции процессов иммунитета.// Екатеринбург: «Наука». -1993. 172С.
- Кетлинский С.А., Симбирцев A.C., Воробьев A.A. Эндогенные иммуномодуляторы.// С.-Петерб.: Гиппократ, 1992. — 256 с.
- Корнева Е.А., Клименко В. М., Шхинек Э. К. Нейрогуморальное обеспечение иммунного гомеостаза.// «Наука». 1978.-С.123−126.
- Корнева Е.А., Шхинек Э. К. Гормоны и иммунная система. JI. «Наука». — 1988.
- И. Лазарева Е., Алехин А. Стимуляторы иммуногенеза.-М. «Медицина» -1985. 132С.
- Плохинский H.A. Алгоритмы биометрии. М. Изд.Моск. университета, -1980.-150С.
- Симбирцев A.C., Конусова В. Г., Кетлинский С. А. Иммуноцитохимический анализ продукции интерлейкина-1бета моноцитами человека// Бюлл. экспер. биол. мед. -1991. № 9. — С. 278−280.
- Симбирцев A.C., Пигарева Н. В., Кетлинский С. А., Калинина Н. М., Сорокин Е. М. Биологическая активность рекомбинантного интерлейкина-1 бета человека при введении in vivo.// Вестник РАМН. 1993. — № 2. — С.18−22.
- Симбирцев A.C. Новые подходы к клиническому применению рекомбинантного интерлейкина-lß- человека.// Медицинская иммунология. 1999. — Т.1,№ 1−2, — С.141−146.
- Хаитов P.M., Вербицкий М. Ш. Онтогенез иммунной системы.// Итоги науки и техники. Серия Иммунология. М.:ВИНИТИ. — 1986. — Т. 14. -С.1−165.
- Шемеровская Т.Г., Ковалева И. Г. Стимуляция СТГ клеточного иммунитета и иммунной памяти.-Б.Э.Б.и М.-1975.-Т.79, N5.-C.78−82.
- Ширшев C.B. Кеворков H.H. Репродуктивные гормоны белково-пептидной природы как регуляторы иммунных реакций. // Успехи современной биологии. 1991. — Т.111,№ 5. — С.683−697.
- Ширшев C.B. Механизмы иммунного контроля процессов репродукции.// Екатеринбург: УрОРАН. 1999. — 382С.
- Ширшев С.В. Роль гормонально цитокиновых взаимодействий в формировании гуморального иммунного ответа.//Проблемы эндокринологии. — 1995. — Т. 111 ,№ 5. — С.683−697.
- Aarden L.A., Brunner Т.К., Cerrottini J.C. et al. Revised nomenclature or antigen-non specific T cell proliferation helper factors (letter).// J. Immunol. -1979.-Vol.123.-P.2928.
- Abbassi V. and Bellanti J.A. Humoral and cell-mediated immunity in growth hormone-deficient children: effect of therapy with human growth hormone.//Pediatr. Res. 1985. — № 19. — P. 299−301.
- Alcami A., Smith G.L. A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection.// Cell. 1992. — Vol.71.- P. l53.
- Allen L.A., Aderem A. Mechanisms of phagocytosis.//Current opinion in Immunology. 1996. — Vol.8. — P.36−40.
- Arend W.P., Smith M.F., Janson R.W., Joslin F.G. Interleukin-1 receptor antagonist and intrleukin -lbeta production in human monocytes are regulated differently.// J. ImmunoL 1991. -Vol.147. — P.1530 -1540.
- Arend W.P.Interleukin-1 receptor antagonist. //Adv. Immunol. — 1993. Vol.54. -P.167−173.
- Argetsinger L.S., Carter-Su C. Mechanism of signaling by growth hormone receptor.//Physiol. Rev. 1996. — Vol.76. — P. 1089−1107.
- Astaldi G., Burgio G.R., Astaldi A., Yalcin B., Meardi G. and Gatti G. Growth hormone and lymphocyte activation.//Lancet. 1972. — Vol. 2. -P.73−75.
- Au BT, Williams TJ, Collins PD. Zymosan-induced IL-8 release from human neutrophils involves activation via the CD lib/CD 18 receptor and endogenous platelet-activating factor as an autocrine modulator. // J. Immunol. 1994. -Vol.152.-P.5411−5419.
- Au, B. T., Teixeira, M. M., Collins P. D., and Williams, T. J. Effect of PDE4 inhibitors on zymosan-induced IL-8 release from human neutrophils: Synergism with prostanoids and salbutamol. // Br. J. Pharmacol. 1998. -Vol. 123,№ 6, — P. 1260−1266.
- Auron P.E. The interleukin 1 receptor: ligand interactions and signal transduction.// Cytokine Growth Factor Rev. 1998. -Vol.9. -P.221 -237.
- Auron P.E., Mosley B., Larsen A., Cerretti D.P., Braedt G., Price V., Gillis S., Henney C., et al. Nucleotide sequence of human monocyte interleukin-1 precursor cDNA.// Proc. Natl. Acad. Sei. USA. 1981. — Vol.81. — P.7907.
- Auron P.E., Warner S.J., Webb A.C., Cannon J.G., Bernheim H.A., McAdam K.J., Rosenwasser L.J., LoPreste G., Mucci S.F., Dinarello C.A. Studies on the molecular nature of human interleukin 1.// J. Immunol. 1987. — Vol.138, № 5. -P. 1447−56
- Auron P.E., Webb A.C. The structure and regulation of the human prointerleukin-1 beta gene. // Ann. Inst. Pasteur.- 1987.- Vol.138.- P.462−469.
- Bagby G.C. Interleukin-1 and hematopoiesis. //Blood Rev. 1989. — Vol.3. -P.152−161,
- Bagrodia S., Derijard B., Davis R.J., Cerione R.A. Cdc42 and PAK-mediated signaling leads to Jun kinase and p38 mitogen-activated protein kinase activation. // J.Biol.Chem.- 1995.- Vol.270. P.27 995−28 002.
- Barnard R., Rowlinson S.W., Waters M.J. An electrostatic model for the interaction between growth hormone and its receptor involving chelation of Ca2+ to the human growth hormone molecule.// J. Theor. Biol. 1989. -Vol.140.-P.355−367.
- Bartke A. Growth hormone and aging.// Endocrine. 1998. -Vol.8. — P. 103 108.
- Baumann G. Growth hormone binding proteins: biochemical characterization and assays. //Acta. Endocrinol. (Copenh). 1991. -Vol.124, Suppl. 2. — P.21−26.
- Baumann G. Growth hormone binding to a circulating receptor fragment~the concept of receptor shedding and receptor splicing. // Exp. Clin. Endocrinol. Diabetes. 1995.-Vol.103.-P.2−6.
- Bazan J.F. A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor beta-chain. // Biochem. Biophys. Res. Commun. 1989. -Vol. 164. — P.788−795.
- Bazzoni F., Gassatella M.A., Rossi F., Ceska M., Dewald B., Baggiolini M. Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8. // J. Exp. Med. 1991.- Vol.173. -P.771−774.
- Beach J.E., Smallridge R.C., Kinzer C.A., Bernton E.W., Holaday J.W., Fein H.G. Rapid release of multiple hormones from rat pituitaries perifused with recombinant interleukin-1. // Life Sci. 1989. -Vol.44. -P. 1−7.
- Beck G., Habicht G.S., Benach J.L., Miller F. Interleukin 1: a common endogenous mediator of inflammation and the local Shwartzman reaction.// J. Immunol. 1986. -Vol.136. -P.3025−3031.
- Benjamin D., Dower S. Human B cells express two types of interleukin-1 receptors. // Blood.- 1990.- Vol.75.- P.2017−2023.
- Bernton E.W., Beach J.E., Holaday J.W., Smallridge R.C., Fein H.G. Release of multiple hormones by a direct action of interleukin-1 on pituitary cells.// Science. 1987.- Vol. 238. — P.519−521.
- Besedovsky H., del Rey A., Sorkin E., Dinarello C.A. immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. // Science. -1986.-Vol.238.-P.524−529.
- Billestrup N., Allevato G., Norstedt G., Moldrup A., Nielsen J.H. Identification of intracellular domains in the growth hormone receptor involved in signal transduction. // Proc. Soc. Exp. Biol. Med. 1994. — Vol.206. — P.205−209.
- Billestrup N., Hansen J.A., Hansen L.H., Moldrup A.H., Galsgaard E.D., Nielsen J.H. Molecular mechanism of growth hormone signalling.//Endocr. J. -1998.-Vol. 45.-P. 41−45.
- Bluet-Pajot M.T., Epelbaum J., Gourdji D., Hammond C., Kordon C. Hypothalamic and hypophyseal regulation of growth hormone secretion.// Cell. Mol. Neurobiol.-1998.-Vol.18.-P.101−123.
- Bonello R.S., Marcus R., Bloch D. and Strober S. Effects of growth hormone and estrogen on T lymphocytes in older women.// J. Am. Geriatr. Soc. 1996-Vol. 44. -P. 1038−1042.
- Born J., Lange T., Hansen K., Molle M., and Fehm H. L. Effects of sleep and circadian rhythm on human circulating immune cells. // J. Immunol. 1997. -Vol.158, № 9, — P. 4454−4464.
- Bovers C.Y. Growth hormone-releasing peptide (GHRP).// Cell. Mol. Life Sci. -1998. Vol. 54. — P.1316−1329.
- Bozzola M., Maccario R., Cisternino M., M. de Amici, Valtorta A., Moretta A., Biscaldi I. and Schimpff R.M. Immunological and endocrinological response to growth hormone therapy in short children.// Acta. Paediatr. Scand. 1988. -Vol. 77.-P. 675−680.
- Bozzola M., Valtorta A., Moretta A., Montagna D., Maccario R., Burgio G.R. Modulating effect of growth hormone (GH) on PHA-induced lymphocyte proliferation.//Thymus. 1988. — Vol.12. — P. 157−165.
- Burgess W., Liu Q., Zhou J., Tang Q., Ozawa A., VanHoy R., Arkins S., Dantzer R., Kelley K.W. The immune-endocrine loop during aging: role of growth hormone and insulin-like growth factor-I.// Neuroimmunomodulation. -1999.-Vol. 6. -P.56−68.
- Burns K., Martinon F., Esslinger C., Pahl H., Schneider P., Bodmer J.L., Di Marco F., French L., Tschopp J. MyD88, an adapter protein involved in interleukin-1 signaling. // J. Biol. Chem. 1998. — Vol.273. — P. 12 203−12 209.
- Calao A., Merola B., Ferone D., Lombardi G. Acromagaly. // J. Clin.Endocrinol. Metab. 1997. — Vol.82. — P.2777−2781.
- Calduch-Giner J.A., Sitja-Bobadilla A., Alvarez-Pellitero P., Perez-Sanchez J. Evidence for a direct action of GH on haemopoietic cells of a marine fish, the gilthead sea bream (Sparus aurata).// J. Endocrinol. 1995. -Vol.146. — P.459−467.
- Campbell G.S., Christian L.J., Carter-Su C. Evidence for involvement of the growth hormone receptor-associated tyrosine kinase in actions of growth hormone.//J. Biol. Chem. 1993. — Vol.268. — P.7427−7434.
- Campbell G.S., Meyer D.J., Raz R., Levy D.E., Schwartz J., Carter-Su C. Activation of acute phase response factor (APRF)/Stat3 transcription factor by growth hormone.//J. Biol. Chem. 1995. — Vol.270.-P.3974−3979.
- Cao Z., Henzel W.J., Gao X. IRAK: a kinase associated with the interleukin-1 receptor.// Science. -1996. Vol.271. -P.1128−1131.
- Cao Z., Xiong J., Takeuchi M., Kurama T., Goeddel D.V. TRAF6 is a signal transducer for interleukin-1.// Nature. 1996. — Vol.383. — P. 443−446.
- Carter-Su C., Smit L.S. Signaling via JAK tyrosine kinases: growth hormone receptor as a model system.// Recent. Prog. Horm. Res. 1998. — Vol.53. -P.61−63.
- Casanueva F.F. Phisiology of growth hormone secretion and action.// Endocrinol. Metab. Clin. North. Am. 1992. — Vol.21. — P.483−517.
- Chen C., Brinkworth R., Waters M.J. The role of receptor dimerization domain residues in growth hormone signaling.//.!. Biol. Chem. 1997. — Vol. 272. — P. 5133−5140.
- Chen H., chuller L. Growth hormone receptor and regulation of genge expression in fetal lymphoid cells.// Mol.Cell.Endocrinol. 1998. — Vol.137. -P.21−29
- Clackson T., Wells J.A. Growth hormone receptor complex // J. Mol. Biol. -1997. Vol.237. — P. 4221−4225.i
- Clackson T., Ultsch M.H., Wells J.A., de Vos A.M. Structural and functional analysis of the 1:1 growth hormone: receptor complex reveals the molecular basis for receptor affinity. // J. Mol. Biol. 1998. — Vol.277. — P. l 111−1128.
- Cornwell R.D., Gollahon K.A. and Hickstein D.D. Description of the leukocyte function-associated antigen 1 (LFA-1 or CD 11a).// Proc. Natl. Acad. Sci. U S A.- 1993. Vol. 90. — P. 4221 -4225.
- Corpas E. Human growth hormone and human aging. // Endocrin. Rev. 1993.- Vol.14. -P.20−39.
- De Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., de Vries J.E. Interleukin-10 inhibits cytokine syntesis by monocytes: an autoregulatory roleof 11−10 produced by monocytes.// J. Exp. Med. 1991. — Vol.174. — P. 12 091 230
- Decandia P., Serrone M., Pestillo L., Caradonna L., Antonaci S., Jirillo E. Role of lymphocyte function-associated antigen-1 on the interplay between lipid A-activated monocytes and polymorphonuclear cells.// Microbios. 1995. -Vol.83. -P.41−47.
- Derfalvi B., Nemet K., Szalai C., Kenesei E., Sallay P., Tulassay T., Falus A. In vitro effect of human recombinant growth hormone on lymphocyte and granulocyte function of healthy and uremic children. // Immunol. Lett. 1998. -Vol.63.-P.41−47.
- Detmers P.A., Powell D.E., Walz A., Clark-Lewis I., Baggiolini M., Cohn Z.A. Differential effects of neutrophil-activating peptide l/IL-8 and its homologues on leukocyte adhesion and phagocytosis. // J. Immunol. 1991. — Vol. 147. -P.4211−4217.
- Dinarello C.A. Biologic basis for interleukin-1 in disease.// Blood. 1996. -Vol.87.-P.2095−2113.
- Dinarello C.A. Interleukin-1 and interleukin-1 antagonism. I I Blood. 1991. -Vol.77.-P. 1627−1652.
- Dinarello C.A. Interleukin-1 and its biologically related cytokines. // J. Immunol. 1989.-Vol.44.-P.153 — 164.
- Dinarello C.A., Thompson R.C. Blocking EL-1: interleukin 1 receptor antagonist in vivo and in vitro.// Immunol. Today. 1991. -Vol.12. — P. 404−410.
- Dower S.K., Bomzstyk K., Sims J.E. Structure of IL-1 receptors.// Prog. Clin. Biol. Res. 1990. -Vol. 349. — P. 241−249.
- Edens A., Talamantes F. Alternative processing of growth hormone receptor transcripts.//Endocrin. 1998. — Vol.19. — P.559−582.
- Eriksson H., Ridderstrle M., Tornqvist H. Tyrosine phosphorylation of the growth hormone (GH) receptor and Janus tyrosine kinase-2 is involved in the insulin-like actions of GH in primary rat adipocytes. // Endocrinology. 1995. -Vol.136.-P.5093−5101.
- Fabris N. and Sorkin E. Relation of lymphoid system and hormones to aging. // Birth Defects. 1975. -Vol. 11. -P. 533−535.
- Faccioli L.H., Souza G.E., Cunha F.Q., Poole S., Ferreira S.H. Recombinant interleukin-1 and tumor necrosis factor induce neutrophil migration in vivo by indirect mechanisms. //Agents Actions. 1990, -Vol.30. — P.344−349.
- Fenton M.J., Clark B.D., Collins K.L., Webb A.C., Rich A., Auron P.E.Transcriptional regulation of the human prointerleukin 1 beta gene.// J. Immunol. 1987.-Vol.138, № 11.-P. 3972−3979.
- Fink J., Beal G. Immulogic aspects of endocrine disease.// J. Jama. 1982.-V.248, № 20. — P.2696−2700.
- Franc N., White F., Ezecowitz R.A. Phagocytosis and development: back to the future.// Current Opinion in Immunology. 1998. — Vol.11. — P.47−52.
- Friend K.E., Radinsky R., McCutcheon I.E. Growth hormone receptor expression and function in meningiomas: effect of a specific receptor antagonist. // J. Neurosurg. 1999. -Vol.91. — P.93−99.
- Friesen H.G., Shiu R.P., Elsholtz H., Simpson S., Hughes J. Prolactin and growth hormone receptors. // Ciba. Found. Symp. 1982. — P.263−278.
- Fry C., Gunter D.R., McMahon C.D., Steele B., Sartin J.L. Cytokine-mediated growth hormone release from cultured ovine pituitary cells.// Neuroendocrinology. 1998. — Vol.68. -P. 192−200.
- Fu Y.K., Arkins S., Wang B.S., Kelley K.W. A novel role of growth hormone and insulin-like growth factor-I. Priming neutrophils for superoxide anion secretion.//J. Immunol. 1991. — Vol.146. — P.1602−1608.
- Gala R.R. and Shevach E.M. Influence of prolactin and growth hormone on the activation of dwarf mouse lymphocytes in vivo.// Proc. Soc. Exp. Biol. Med. -1993.-Vol. 204. -P. 224−230.
- Gala R.R. Prolactin and growth hormone in the regulation of the immune system. //Proc. Soc. Exp. Biol. Med. Vol. 198. — 1991. -P. 513−527.
- Geffiier M.E., Bersch N., Bailey R.C. and Golde D.W. Growth hormone induces resistance to the mitogenic action of insulin through local IGF-I. Studies in normal and Pygmy T-cell lines.// Diabetes. 1994. — Vol. 43. -P. 68−72.
- Geffner M.E., Bersch N., Lippe B.M., Rosenfeld R.G., Hintz R.L. and Golde D.W. Growth hormone mediates the growth of T-lymphoblast cell lines via locally generated insulin-like growth factor-I.// J. Clin. Endocrinol. Metab. -1990.-Vol. 71.-P. 464−469.
- Gelato M.C. Aging and immune function: a possible role for growth hormone. // Horm. Res.-1996.- Vol.45. -P. 46−49.
- Giesbert S., Panzer S., Kovar H., Fischer S., Printz D., Gadner H. and Panzer-Grumayer E.R. Acute leukemias express a functional receptor for the human growth hormone.// Ann. Hematol. -1997. Vol. 74. — P. 253−257.
- Godambe S.A., Chaplin D.D., Bellone C.J. Regulation of IL-1 gene expression: differential responsiveness of murine macrophage lines. // Cytokine. 1993. -Vol.5.-P. 327−335.
- Goya R.G., Brooks K., Meites J. A comparison between hormone levels and T lymphocyte function in young and old rats. // Mech. Ageing Dev. 1991. — Vol. 61. -P.275−285.
- Granowitz E.V., Clark B.D., Mancilla J., Dinarello C.A. Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor. // J. Biol. Chem. 1991. — Vol.266. -P.14 147−14 150.
- Green H., Morikawa M., Nixon T. A dual effector teory of growth hormone action.//Differentiation. 1985. — Vol.29. — P.195 — 198.
- Grinevich I. and Elqchits T.V.Current concepts of the interaction between the body’s endocrine and immune systems.// Fiziol. Zh. 1981. — Vol.27. — P.229−236.
- Hackett R.H., Wang Y.D., Larner A.C. Mapping of the cytoplasmic domain of the human growth hormone receptor required for the activation of Jak2 and Stat proteins. // J. Biol. Chem. 1995. — Vol.270. — P.21 326 -21 330.
- Han Y., Leaman D.W., Wailing D., Rogers N.C., Groner B., Kerr I.M., Wood W.I., Stark G.R. Participation of JAK and STAT proteins in growth hormone-induced signaling.// J. Biol. Chem. -1996. Vol.271P.5947−5952.
- Hansen P., CliftonBligh P. Deficiency of the growth hormone-insulin-like growth factor-I axis potentially involved in age-related alterations in body composition. // Gerontology. 1998. — Vol.44. — P. 245−245.
- Haraldsson A., Van der Burgt C.J., Weemaes C.M., Otten B., Bakkeren J.A. and Stoelinga G.B. Antibody deficiency and isolated growth hormone deficiency in a girl with Mulibrey nanism.// Eur. J. Pediatr. 1993. — Vol. 152. -P. 509−512.
- Hattory N., Inagaki C. Immunological aspects of human growth hormone and prolactine.// Domest. Anim. Endocrin. 1997. — Vol.15. — P.371−375.
- Hochberg Z, Amit T, Youdim MB. The growth hormone binding protein as a paradigm of the erythropoietin superfamily of receptors. // Cell. Signal. 1991. -Vol.3.-P. 85−91.
- Hocquette J.F., Postel-Vinay M.C., Djiane J., Tar A., Kelly P.A. Human liver growth hormone receptor and plasma binding protein: characterization and partial purification. // Endocrinology. 1990. — Vol. 127. — P. 1665−1672.
- Horikawa R., Tanaka T., Katsumata N., Tanae A. The regulatory effect of growth hormone on growth hormone-binding protein in human serum. // Endocr. J. 1998.-Vol.45.-P:l 13−115.
- Hosoda H., Kojima M., Matsuo H., Kangawa K. Purification and characterization of rat des-GLN4-ghrelin, a second endogenous ligand for growth secretogogue receptor.// JJBiol. Chem. 2000. — Vol.65. — P.34−45.
- Howard A.D., Kostura M.J., Thornberry N. et al. IL-1-converting ensime requires aspartic acid residues for processing of the IL-1 beta precursor at two distinct sites and does not cleave 31 kDa IL-lalfa.// J.Immunol.- 1991.-Vol.147.- P.2964−2969.
- Huang J., Gao X., Li S., Cao Z. Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein. // Proc. Natl. Acad. Sci. U S A. 1997. — Vol. 94.-P.12 829−12 832.
- Hull K.L., Thiagarajah A., Harvey S. Cellular localization of growth hormone receptors/binding proteins in immune tissues. // Cell. Tissue. Res. 1996. -Vol. 286. -P.69−80.
- Hyashida T., Li C.H. The influence of adrenocorticotropic and grown hormones on antibody formation .// J.Exp.Med. 1977. — V.105, № 2. — P. 93−98.
- Inoue T., Saito H., Fukushima R., Inaba T., Lin M.T., Fukatsu K., Muto T. Growth hormone and insulinlike growth factor I enhance host defense in a murine sepsis model.// Arch. Surg. 1995. — Vol.130. — P. l 115−1122.
- Isalsson O.G., Lindahl A., Nalsson A., Isgaard J. Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. // Endocrinol. 1987. -Vol.8. — P.426−438.
- Isler P., Vey E., Zhang J.H., Daer J.M. Cell surface glycoprotein expressed on activated human T cells induce production of interleukin-1 beta by monocytic cells: a possible role of CD69. // Eur.Cytokine.Netw. 1993. — Vol.4. — P. 1526.
- Ito R. Interleukin 1 alfa act as an autocrine growth stimulator for human gastric carcinoma cell.// Cancer Reserch. 1993. — Vol.53. — P.4102−4106.
- Kao T.L., Supowit S.C., Thompson E.A. and Meyer W.J. Immunoreactive growth hormone production by human lymphocyte cell lines.// Cell. Mol. Neurobiol. 1992. — Vol.12. — P. 483−498.
- Kassem, M. Cellular and molecular effects of growth hormone and estrogen on human bone cells. // APMIS. 1997. — Vol.105, № 7. — P.123−125.
- Kelley K.W. Immunologic roles of two metabolic hormones, growth hormone and insulin-like growth factor-I, in aged animals. // Nutr. Rev. 1995. — Vol. 53. -P. 95−103.
- Kelley K.W. The role of growth hormone in modulation of the immune response.//Ann. N. Y. Acad. Sei. 1990. — Vol. 594. — P. 95−103.
- Kelley K.W., Arkins S. and Li Y.M. Growth hormone, prolactin, and insulinlike growth factors: new jobs for old players.// Brain. Behav. Immun. 1992. -Vol. 6.-P. 317−326.
- Kelley K.W., Arkins S., Minshall C., Liu Q., Dantzer R. Growth hormone, growth factors and hematopoiesis.// Horm. Res. 1996. — Vol. 45. — P.38−45.
- Kelley K.W., Davila D.R., Brief S., Simon J. and Arkins S. A pituitary-thymus connection during aging. // Ann. N.Y. Acad. Sci. 1988. — Vol. 521. — P. 88−98.
- Kelly P.A., Djiane J., Postel-Vinay M.C., Edery M. The prolactin/growth hormone receptor family. // Endocr. Rev. 1991. — Vol. 12. — P.235−251.
- Kelly P.A., Goujon L., Sotiropoulos A., Dinerstein H., Esposito N., Edery M., Finidori J., Postel-Vinay M.C. The GH receptor and signal transduction. // Horm. Res. 1994. — Vol.42. — P. 133−139.
- Khansari D.N., Gustad T. Effects of long-term, low-dose growth hormone therapy on immune function and life expectancy of mice. Mech. Ageing Dev. -1991.-Vol.57.-P.87−100.
- Kiess W. and Belohradsky B.H. Endocrine regulation of the immune system. // Klin. Wochenschr. Vol. 64. — 1986. — P. 1−7.
- Kiess W., Butenandt O. Specific growth hormone receptors on human peripheral mononuclear' cells: reexpression, identification, and characterization. // J. Clin. Endocrinol. Metab. 1985. -Vol.60. -P.740−746.
- Knop J., Martin M.U. Effects of IL-1 receptor-associated kinase (IRAK) expression on IL-1 signaling are independent of its kinase activity. // FEBS Lett.- 1999.-Vol.448.-P.81−85.
- Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is growth hormone releasing acylated peptide from stomach.// Nature. — 1999.- Vol.402.-P.656−660.
- Krane S.M., Goldring M.B., Goldring S.R. Cytokines.// Ciba. Found. Symp. -1988.-Vol.136.-P.239−256
- Krueger J.M., Fang J., Taishi P., Chen Z., Kushikata T., Gardi J. Sleep. A physiologic role for IL-1 beta and TNF-alpha. // Ann, N. Y. Acad. Sci. 1998. -Vol.856.-P. 148−159.
- Krueger J.M., Majde J.A. Cytokines and sleep. // Int. Arch. Allergy. Immunol. -1995.-Vol.106.-P.97−100.
- Krueger J.M., Obal F. Growth hormone-releasing hormone and interleukin-1 in sleep regulation.// FASEB J. 1993. — Vol.7. — P.645−652.
- Krueger J.M., Toth L.A., Floyd R., Fang J., Kapas L., Bredow S., Obal F. Sleep, microbes and cytokines. // Neuroimmunomodulation. 1994. — Vol.1. — P.100−109.
- Lachman L.B. Natural and recombinant interleukin 1 beta is cytotoxic for human melanoma cells. // J. Immunol. 1987. — Vol.136. — P.3089−3102.
- Laurence J., Grimison B., Gonenne A. Effect of recombinant human growth hormone on acute and chronic human immunodeficiency virus infection in vitro. //Blood. 1992. — Vol.79. — P.467−472.
- Liao G, Simon SR. Temporal down-regulation of Fc gamma RIII expression and Fc gamma receptor-mediated phagocytosis in human monocyte-derived macrophages induced by TNF-alpha and EL-1 beta.// J. Leukoc. Biol. 1994. -Vol.55. — P.702.-710.
- Lincoln D.T., Sinowatz F., Temmim-Baker L., Baker H.I., Waters M.J. Growth hormone receptor expression in the nucleus and cytoplasm of normal and• neoplastic cells. // Histochem. Cell. Biol. 1998. — Vol. 109. — P. 14.1 -159.
- Liu J., LeRoith D. Insulin-like growth factor I is essential for postnatal growth in response to growth hormone.// Endocrinology. 1999. — Vol.140. — P.5178 -5184.
- Liu N.D., Mertani B.C., Norstedt G., Tornell J., Lobie P.E. Mode of the autocrine/paracrine mechanism of growth hormone action. // Exp. Cell. Res. -1997.-Vol. 237.-P. 196−206.
- Lombard! G., Colao A., Ferone D. Effect of growth hormone on cardiac function.//Horm. Rev. 1997. — Vol.48. — P.38−42.
- Lovet D. macrophage cytotoxicity: interleukin 1 as mediator of tumor cytostasis. //J/Immunol. 1986. — Vol. 136. — P.340−347.
- Loverro G., Cantatore F.P., Sasanelli B., Carrozzo M., BosciaF.M., Selvaggi L. Role of interleukin-1-alpha and growth factors in postmenopausal osteoporosis. //Minerva. Ginecol. 1994. — Vol.46. — P. 15−20.
- Maes M, Maiter D, Massa G, Ketelslegers JM. Growth hormone receptor and binding protein: roles in cellular responsiveness to growth hormone. // Ann. Endocrinol. (Paris). 1995. — Vol.56. — P.253−258.
- Maheshwari H., Lillioja S., Castillo C.E., Mercado M., Baumann G. Growth hormone-binding protein in human lymph. // J. Clin. Endocrinol. Metab. 1995. — Vol.80. — P.3582−3584.
- Makinodan T. Studies on the influence of age on immune response to understand the biology of immunosenescence. // Experimental gerontology. -1998. Vol. 33, №½. — P.27−38.
- Mallmann P., Mallmann R. and Nadstawek R. Circadian rhythm of cellular and humoral immunologic parameters. // Immun. Infekt. 1989. — Vol.17. — P. 9799.
- March K.J., Mosley B., Larsen A. et al. Cloning, sequence and expression of two distinct interleukin-1 complementary DNAs.// Nature.- 1985.- Vol.315. -P.641−647.
- Marcus R., Hoffman A.R. Growth hormone as therapy for older men and women.//Annu. Rev. Pharmacol. Toxicol. 1998.-Vol.38.-P.45−61.
- Martha P.M.J., Reiter E.O., Davila N., Shaw M. A., Holcombe J.H., Baumann G. Serum growth hormone (GH)-binding protein/receptor: an important determinant of GH responsiveness. // J. Clin. Endocrinol. Metab. 1992. — Vol. 75.-P. 1464−1469.
- Maschera B., Ray K., Burns K., Volpe F. Overexpression of an enzymically inactive interleukin-1-receptor-associated kinase activates nuclear factor-kappaB. // Biochem. J. 1999. — Vol.339. — P. 227−231.
- Mayo K.E.Molecular cloning and expression of pituitary-specific receptor for growth hormone-releasing hormone. // Mol. Endocrinol. 1992. — Vol.6. -P. 1734−1744.
- Mazzoccoli G., Correra M., Bianco G., De Cata A., Balzanelli M., Giuliani A., Tarquini R. Age-related changes of neuro-endocrine-immune interactions in healthy humans. // J. Biol. Regul. Homeost. Agents. 1997. — Vol.11. — P.143−147.
- McCann S.M., Kimura M., Karanth S., Yu W.H., Rettori V. Nitric oxide controls the hypothalamic-pituitary response to cytokines. // Neuroimmunomodulation. 1997. — Vol.4. — P.98−106.
- McCann S.M., Lyson K., Karanth S., Gimeno M., Belova N., Kamat A., Rettori V. Mechanism of action of cytokines to induce the pattern of pituitary hormone secretion in infection. // Ann. N. Y. Acad. Sci. 1995. — Vol.771. — P.386−395.
- McCormick A., Brady H., Theil L., Karin M. Regulation of the pituitary-specific homeobox gene GHF1 by cell-autonomous and environmental cues.// Nature. -1990. — Vol.345. P.829−832.
- Mol J.A., Van Garden E., Seman P.J., Wolswinkel J., Rijinberk A., Rutteman G. Growth hormone mRNA in mammary gland tumours of dog and cats.// J. Clin. Invest. 1995. — Vol.95. — P.2028−2034.
- Murphy WJ., Durum S.K., Longo D.L. Differential effects of growth hormone and prolactin on murine T cell development and function. // J. Exp. Med. -1993.-Vol.178.-P.231−236.
- Murphy W.J., Durum S.K.,. Anver M. R and Longo D.L. Immunologic and hematologic effects of neuroendocrine hormones. Studies on DW/J dwarf mice.//J. Immunol. 1992. — Vol. 148. — P. 3799−3805.
- Murphy W.J., Rui H. and Longo D.L. Effects of growth hormone and prolactin immune development and function.// Life Sci. 1995. — Vol. 57. — P. 1−14.
- Mustafa A., Nyberg F., Mustafa M., Bakhiet M., Mustafa E., Winblad B., and Adem, A. Growth hormone stimulates production of interferon-gamma by human peripheral mononuclear cells. //Horm. Res. 1997. — Vol. 48,№ 1. — P. 11−15.
- Muzio M., Ni J., Feng P., Dixit V.M. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. // Science. 1997. — Vol.278. — P.1612−1615.
- Niimi M., Sato M., Wada Y., Tamaki M., Takahara J., Kawanishi K. Analysis of growth hormone release from rat anterior pituitary cells by reverse hemolytic plaque assay: influence of interleukin-1. //Life Sci. 1994. — Vol.55. -P.1807−1813.
- O’Neill L.A., Greene C. Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. // J. Leukoc. Biol. 1998. — Vol. 63. -P.650−657.
- Ono M., Takayama Y., Rang-Weawer M., Sakata S., Yasunaga T., Nasa T., Kawauchi H. cDNA cloning of somatolactin, a pituitary protein related to growth hormone and prolactin. // Proc. Natl. Acad. Sci. USA 1990. — Vol.87. -P .4330−4334.
- Orencole S.F., Vannier E., Dinarello C.A. Circulating levels of IL-1 soluble receptors in health and after endotoxin or IL-2 administration.// Cytokine. -1995. Vol.6.-P.554−561.
- Palmetshofer A., Zechner D., Luger T.A., Barta A. Splicing variants of the human growth hormone nRNA Detection in pituitary, mononuclear cells and dermal fibroblastes.// Mol.Cell.Endocrinol. — 1995. — Vol.113. — P.225−234.
- Payne L.C., Krueger J.M. Interactions of cytokines with the hypothalamus-pituitary axis.//J. Immunother. 1992. -Vol.12. -P.171−173.
- Payne L.C., Obal F., Opp M.R., Krueger J.M. Stimulation and inhibition of growth hormone secretion by interleukin-1 beta: the involvement of growth hormone-releasirig hormone. // Neuroendocrinology. 1992. — Vol. 56. — P. l 18 123.
- Pierpaoli W., Sorkin E. Hormones and immunological capacity. // J.Immunol.-1968.-V.101 .- P.1036−1043.
- Postel-Vinay M.C. Growth hormone- and prolactin-binding proteins: soluble forms of receptors. // Horm. Res. 1996. — Vol.45. — P.178−181.
- Postel-Vinay M.C., De Mello C., Gagnerault M.C. and Dardenne M. Growth hormone stimulates the proliferation of activated mouse T lymphocytes.// Endocrinology.-Vol. 138. 1997.-P. 1816−1820.
- Postel-Vinay M.C., Finidori J., Goujon L., Martini J.F., Delehaye Z., Kelly P.A. Growth hormone receptor. // Ann. Endocrinol. (Paris). 1991. — Vol.52. -P.469−473.
- Postel-Vinay M.C., Finidori J., Sotiropoulos A., Dinerstein H., Martini J.F., Kelly P.A. Growth hormone receptor. Structure and signal transduction. // Ann. Endocrinol. (Paris). 1995. — Vol.56. — P.209−212.
- Postel-Vinay M.C., Kelly P.A. Growth hormone receptor signalling. // Baillieres. Clin. Endocrinol. Metab. 1996. — Vol. 10. — P.323−336.
- Rabinovitch A., Quigley C. and Rechler M.M. Growth hormone stimulates islet B-cell replication in neonatal rat pancreatic monolayer cultures. // Diabetes. -1983.- Vol. 32. -P. 307−312.
- Rapaport R., Petersen B, Skuza K.A., Heim M., Goldstein S. Immune functions during treatment of growth hormone-deficient children with biosynthetic human growth hormone. // Clin. Pediatr. (Phila). -1991. Vol.30. — P.22−27.
- Renner U., Newton C.J., Pagotto U., Sauer J., Arzt E., Stalla G.K. Involvement of interleukin-1 and interleukin-1 receptor antagonist in rat pituitary cell growth regulation.//Endocrinology. 1995.- Vol. 136. — P.3186−3193.
- Rettori V., Jurcovicova J., McCann S.M. Central action of interleukin-1 in altering the release of TSH, growth hormone, and prolactin in the male rat. // J. Neurosci. Res. 1987. -Vol.18. -P.179−183.
- Roubenoff R. Hormones, cytokines and body composition: can lessons from illness be applied to aging?// J. Nutr. 1993. -Vol.123. -P.469−473.
- Rubartelli A., Cozzolino F., Talio M., Sitia R. A novel secretory pathway for interleukin-1 beta, a protein lacking a signal sequence. // EMBO J. 1990. -Vol.9.-P.1503−1510.
- Saggese G., Federico G., Cinquanta L. In vitro effects of growth hormone and other hormones on chondrocytes and osteoblast-like cells. // Acta. Paediatr. Suppl. 1993. — Vol.82, Suppl.391. — P.54−59.,
- Sakai M., Kobayashi M., Kawauchi H. In vitro activation of fish phagocytic cells by GH, prolactin and somatolactin. // J. Endocrinol. 1996. — Vol.151. -P.113−118.
- Scarborough D.E. Cytokine modulation of pituitary hormone secretion.// Ann. N. Y. Acad. Sci. 1990. -Vol.594.-P. 169−187.
- Schimpff R.M., Repellin A.M. Production of interleukin-1-alpha and interleukin-2 by mononuclear cells in healthy adults in relation to different experimental conditions and to the presence of growth hormone. // Horm. Res. -1990.-Vol.33.-P. 171−176.
- Schindler R., Gelfand J.A., Dinarello C.A.Dissociation between interleukin-lbeta mRNA and protein synthesis in human peripheral blood cells. // Blood. -1990.-Vol.76.-P.1631−1638.
- Serri O., StJacques P., Sartippour M., and Renier G. Alterations of monocyte function in patients with growth hormone (GH) deficiency: Effect of substitutive GH therapy.// J. Clin. Endocrinol. Metab. 1999. — Vol.84, № 1. — P. 58−63.
- Shemerovskaia T.G. and Kovaleva I.G. Stimulation of cellular immunity and immunologic memory be somatotropic hormone. // Biull. Eksp. Biol. Med. -Vol. 79.-1975. -P. 78−80.
- Shinkai S., Konishi M., and Shephard R. J. Aging and immune response to exercise. // Can. J. Physiol. Pharmacol. 1998. — Vol. 76, № 5. — P. 562−572.
- Shirakawa F., Tanaka Y., Ota T., Suzuki H., Eto S., Yamashita U. Expression of interleukin-1 receptors on human peripheral T cells.// J.Immunol. 1987. — Vol. 138. -P.4243−4256.
- Simbirtsev A.S., Pigareva V.G., Kalinina N.M., Sorokin E.M., Ketlinskii S.A. The biological activity of human recombinant interleukin-1 beta when administered in vivo. // Vestn. Ross. Akad. Med. Nauk. 1993.- P.18−22.
- Sims J.E., Gayle M.A., Slack J.L., Anderson M.R., Bird T.A., Giri J.G., Colotta F. et al. Interleukin-1 signaling occurs exclussivly via the type I receptor.// Proc. Natl. Acad. Sci.USA. 1993. — Vol.90. — P.6155−6167.
- Skibeli V., Rokkones E., Gautvik K.M. Growth hormone and prolactin receptors belong to a new receptor family. Biological and medical aspects. // Tidsskr. Nor. Laegeforen. 1993.-Vol.113.-P.725−730.
- Slack J.L., Schokly K. et al. Identification of two major sites in the type I interleukin-1 receptor cytoplasmic region responsible for coupling to pro-inflamatory signaling pathways.// J. Biol. Chem. 1998. — Vol.275, — P. 46 704 678.
- Stred S.E., Stubbart J.R., Argetsinger L.S., Shafer J.A., Carter-Su C. Demonstration of growth hormone (GH) receptor-associated tyrosine kinase activity in multiple GH-responsive cell types. // Endocrinology. 1990. — Vol.127.-P.2506−2516.
- Stylianou E., O’Neil L., Rawlinson L. et al. Interleukin-1 induces NF-kappa B throwgh its type I but not its type II receptor in limphocytes.// J.Biol.Chem.-1992. Vol.267.-P.15 836−15 841.
- Takada Y., Bando H., Miyamoto Y., Kosaka M. and Sano T. Effect of growth hormone on immune function in normal and hypophysectomised rats.// Nippon. Naibunpi. Gakkai. Zasshi. 1991. — Vol. 67. — P. 1162−1177.
- Takagi K., Suzuki F., Barrow R.E., Wolf S.E., Herndon D.N. Recombinant human growth hormone modulates Thl and Th2 cytokine response in burned mice.//Ann. Surg. 1998. — Vol.228. — P. 106−111.
- Talwar G.P., Hanjan S.N., Kidwai Z., Gupta P.D., Mehrotra N.N., Saxena R. and Bhattarai Q. Growth hormone action on thymus and lymphoid cells. // Amsterdam, Excerpta Medica, 1976. — Vol.3. — P.54−56.
- Tannenbawm G.S. Neuroendocrine control of growth hormone secretion.// Acta. Paediatr. Scand. Suppl. 1991. — Vol.372. — P.5−16.
- Thellin O., Coumans B., Devos S., Hooghe-Peters E.L., Zorzi W., Igout A., Heinen E., Hooghe R. Limited effects of placental and pituitary growth hormone on cytokine expression in vitro.// Eur. Cytokine Netw. 2000. — Vol. 11. — P. 452−455.
- Thomas H., Green I.C., Wallis M., Aston R. Heterogeneity of growth-hormone receptors detected with monoclonal antibodies to human growth hormone. // Biochem. J. 1987. — Vol.243. — P.365−372.
- Thomas J.A., Allen J.L., Tsen M., Dubnicoff T., Danao J., Liao X.C., Cao Z., Wasserman S.A. Impaired cytokine signaling in mice lacking the IL-1 receptor-associated kinase. // J. Immunol. 1999. — Vol. 163. — P.978−984.
- Tritos N.A., Mantzoros C.S. Recombinant human growth hormone: Old and novel uses.//Am. J.Med.- 1998.-Vol.105.-P. 44−57.
- Tseng Y.H., Kessler M.A., Schuler L.A. Regulation of interleukin (IL)-1 alpha, IL-1 beta, and IL-6 expression by growth hormone and prolactin in bovine thymic stromal cells. // Mol. Cell. Endocrinol. 1997. — Vol.128. — P. l 17−127.
- Ucla C., Roux-Lombard P., Fey S., Daer J.M., March B. Interferon gamma drastically modifies the regulation of interleukin-1 genes by endotoxin in U937 cells.//J.Clin. Investig. 1990.-Vol. 85.-P. 185−201.
- Varma S., Sabharwal P., Sheridan J.F., Malarkey W.B. Growth hormone secretion by human peripheral blood mononuclear cells detected by an enzyme-linked immunoplaque assay. // J. Clin. Endocrinol. Metab. 1993. — Vol. 76. -P.49−53.
- Vig E., Green M., Liu Y., Donner D.B., Mukaida N., Goebl M.G., Harrington M.A. Modulation of tumor necrosis factor and interleukin-1-dependent NF-kappaB activity by mPLK/IRAK. // J. Biol. Chem. 1999. — Vol. 274. -P. 13 077−13 084.
- Wakai K., Tsushima T., Murakami H., Isozaki O., Demura H., Nozoe Y., Yamada H. Protein kinase C (PKC)-mediated growth hormone (GH) actions. // Endocr. J. 1998. — Vol.45. — P.97−99.
- Wang Y.D., Wong K., Wood W.I. Intracellular tyrosine residues of the human growth hormone receptor are not required for the signaling of proliferation or Jak-STAT activation. // J. Biol. Chem. 1995. — Vol.270. — P.7021−7024.
- Warwick-Davies J., Lowrie D.B., Cole P.J. Growth hormone is a human macrophage activating factor. Priming of human monocytes for enhanced release ofH202. //J. Immunol. 1995. — Vol.154. -P.1909−1918.
- Watanabe N., Kobayashi Y. Selective release of a processed form of interleukin 1 alpha.// Cytokine. 1994. — Vol.6. — P.597−601.
- Wells J.A. Binding in the growth hormone receptor complex. // Proc. Natl. Acad. Sci. U S A. 1996.-Vol.93.-P. 1−6.
- Wells J.A., Cunningham B.C., Fuh G., Lowman H.B., Bass S.H., Mulkerrin M.G., Ultsch M., deVos A.M. The molecular basis for growth hormone-receptor interactions. // Recent. Prog. Horm. Res. 1993. — Vol.48. — P.253−275.
- Wesche H., Henzel W.J., Shillinglaw W., Li S., Cao Z. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. // Immunity. 1997. — Vol.7.-P.837−847.
- Wiedermann C J., Niedermuhlbichler M., Beimpold H., Braunsteiner H. In vitro activation of neutrophils of the aged by recombinant human growth hormone. // J. Infect. Dis. 1991.- Vol.164. — P.1017−1020.
- Wu H., Devi R., Malarkey W.B. Localization of the growth hormone messenger ribonucleic acid in the human immune system a clinical research center study.// J.Clin. Endo.Metab. — 1996.- Vol.81. — P.1278−1282.
- Yamin T.T., Miller D.K. The interleukin-1 receptor-associated kinase is degraded by proteasomes following its phosphorylation. // J. Biol. Chem. -1997. Vol.272. — P.21 540−21 547.
- Yang Y., Guo L., Ma L., Liu X. Expression of growth hormone and insulin-like growth factor in the immune system of children. // Horm. Metab. Res. 1999. -Vol.31.-P.380−384.
- Yong K., Khwaja A. Leucocyte cellular adhesion molecules. // Blood. Rev. -1990.-Vol.4.-P.211−225.
- Yoshida A., Ishioka C., Kimata H., Mikawa H. Recombinant human growth hormone stimulates B cell immunoglobulin synthesis and proliferation in serumfree medium. // Acta. Endocrinol. (Copenh). 1992. — Vol. 126. — P.524−529.
- Yosizato H., Fujikawa T., Soya H. The growth hormone gene is expressed in the lateral hypotalamus: enchancement by GH-realising hormone and repression by restant stress.//Endocrinol. 1998. — Vol.139.-P.2545−2551.
- Zhu T., Goh E.L. Growth hormone stimulates the tyrosine phosphorilaiion and association of p 125 focal adgesion kinase (FAK) with JAK-2: FAK is not required for stat-madiated transcription.// J.Biol.Chem. 1998. — Vol. 96. -P.7172−7198.